Related Experiment Videos
Poor outcome in progressive sclerosing cholangitis after septic shock
H Kulaksiz1, D Heuberger, S Engler
1Department of Internal Medicine, Division of Gastroenterology, University Hospital Ulm, Germany. hasan.kulaksiz@uniklinik-ulm.de
Endoscopy
|February 12, 2008
Summary
Progressive sclerosing cholangitis following septic shock leads to extremely poor survival without liver transplantation. This condition requires consideration in patients with cholestasis post-septic shock intensive care unit treatment.
Area of Science:
- Hepatology
- Gastroenterology
- Critical Care Medicine
Background:
- Progressive sclerosing cholangitis (PSC) post-septic shock is an emerging diagnosis.
- This study evaluates long-term outcomes in patients with PSC after septic shock.
Purpose of the Study:
- To assess the prognosis and clinical course of patients diagnosed with progressive sclerosing cholangitis following septic shock.
- To identify key characteristics and outcomes in this patient cohort.
Main Methods:
- Retrospective analysis of 29 patients treated between 1995-2007.
- Inclusion criteria: cholestatic liver disease, no prior hepatobiliary disease, ICU stay for septic shock (trauma, cardiac surgery, infection, etc.).
- Diagnostic methods included ERCP and liver biopsy; therapeutic interventions involved endoscopic procedures.
Main Results:
- ERCP revealed multiple bile duct stenoses and rarefaction; biopsies showed fibrosing cholangitis.
- Endoscopic therapy included material removal, dilation, and stenting.
- High mortality rate: 19 of 29 patients died within the follow-up period.
- Actuarial survival free of liver transplantation was 55% at 1 year and 14% at 6 years, with a median survival of 1.1 years.
Conclusions:
- Progressive sclerosing cholangitis post-septic shock is associated with a very poor prognosis and significantly shortened survival.
- Early consideration of this diagnosis is crucial for patients developing cholestasis after septic shock.
- Liver transplantation is a critical intervention for survival in these patients.
Related Concept Videos
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...